Discover our latest insights, stories, and perspectives
Lipfendra (enlicitide) is the first oral PCSK9 inhibitor, approved by the FDA in July 2026 at a list price of $315 a month.
B12 deficiency or low B12 levels have been estimated to affect about 40% of people over 60 years of age, and about 40% of the general population may be on the lower end of normal. Vitamin B12 deficiency can look like the signs and symptoms of diseases that are commonly associated with aging, such as...
Cutting meat and dairy for just a few weeks triggers measurable changes in metabolism, cholesterol regulation, and gene activity
A 2026 study found 98% of 113 personal care and cleaning products contained unlisted chemicals
Stanford researchers blocked a single aging protein to restore cartilage growth in joints.
Allergies…one of the most common presentations I see in clinical practice. From the mild to the serious, from food to dust, animal fur, and the ‘general unknown’. There are growing insights and evidence of the role gut microbes play in allergies. And, as we know, the microbiome plays a huge role in immune regulation –...
A 2026 study in Cell Host & Microbe found that saliva cancer prediction using oral microbiome analysis outperformed standard stool-based
Oregon's first legal psilocybin program tracked 346 participants for three months.
New 2026 AHA research on coffee heart health shows moderate coffee may lower risk of heart disease, stroke, AFib, and type 2 diabetes
A 2026 report in the American Journal of Clinical Nutrition finds that raising potassium intake alongside cutting sodium may lower blood
Children with autism spectrum disorder (ASD) are at higher risk of medical issues and are more prone to gastrointestinal (GI) disorders, which can worsen the symptoms of ASD, significantly affecting their health, learning, and development, and impacting their behavior. Gastrointestinal health in children with ASD has become an important area of research, with researchers looking...
A 2026 Heidelberg study found boredom predicts hair-pulling episodes more reliably than anxiety
